Literature DB >> 15795121

HLA DR B1*04, *07-restricted epitopes on Keratin 17 for autoreactive T cells in psoriasis.

Z Shen1, G Wang, J-Y Fan, W Li, Y-F Liu.   

Abstract

BACKGROUND: Psoriasis is a T cell-mediated inflammatory skin disease. Recent evidence suggests that activated CD4+ helper T lymphocytes of the Th1 phenotype play an important role in the pathogenesis of the disease. For psoriatic autoreactive T cells, Keratin 17 is a major target antigen and an epitope containing ALEEAN sequence has been described, but other psoriasis-related epitopes are still unknown.
OBJECTIVE: To identify the HLA DR B1*04, *07-restricted T cell epitopes on Keratin 17.
METHODS: HLA DRB1*04, *07-restricted T cell epitope regions on Keratin 17 were predicted based on related software and internet servers. Keratin 17 gene was amplified from psoriatic epidermis and the proteins of the predicted epitope regions were expressed, identified and purified. T cells from psoriatic patients reacted in cultivation with peptide-major histocompatibility complex (p-MHC) compound, then the level of cell proliferation and the concentration of interferon-gamma in culture supernatant were detected. After the psoriasis-related epitope regions were narrowed down, the epitopes on them were predicted further. These epitopes were then expressed and validated by T cell response in vitro.
RESULTS: Four epitopes--S1 (118-132), S2 (169-183), S4 (323-337) and S4 (348-362) can stimulate the proliferation and interferon-gamma production of psoriatic T cells more effectively than other epitopes (p<0.01) and react weakly with the T cells from healthy volunteers (p>0.05).
CONCLUSION: Epitopes S1 (118-132), S2 (169-183), S4 (323-337) and S4 (348-362) are immunodominant DR B1-restricted T cell epitopes for psoriasis. Among them, S1 (118-132) contains the ALEEAN sequence while the others with different amino acid sequence have not been reported before. Further studies based on these peptides would provide a more complete understanding of the immunological basis of psoriasis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15795121     DOI: 10.1016/j.jdermsci.2005.01.001

Source DB:  PubMed          Journal:  J Dermatol Sci        ISSN: 0923-1811            Impact factor:   4.563


  11 in total

1.  Psoriasis patients demonstrate HLA-Cw*06:02 allele dosage-dependent T cell proliferation when treated with hair follicle-derived keratin 17 protein.

Authors:  Milyausha Yunusbaeva; Ruslan Valiev; Fanil Bilalov; Zilya Sultanova; Leyla Sharipova; Bayazit Yunusbayev
Journal:  Sci Rep       Date:  2018-04-17       Impact factor: 4.379

2.  The IL-17A-producing CD8+ T-cell population in psoriatic lesional skin comprises mucosa-associated invariant T cells and conventional T cells.

Authors:  Marcel B M Teunissen; Nataliya G Yeremenko; Dominique L P Baeten; Saskia Chielie; Phyllis I Spuls; Menno A de Rie; Olivier Lantz; Pieter C M Res
Journal:  J Invest Dermatol       Date:  2014-06-18       Impact factor: 8.551

3.  The pro-inflammatory cytokine IL-22 up-regulates keratin 17 expression in keratinocytes via STAT3 and ERK1/2.

Authors:  Wei Zhang; Erle Dang; Xiaowei Shi; Liang Jin; Zhenzhen Feng; Lei Hu; Yan Wu; Gang Wang
Journal:  PLoS One       Date:  2012-07-13       Impact factor: 3.240

4.  Sulfamethoxazole induces a switch mechanism in T cell receptors containing TCRVβ20-1, altering pHLA recognition.

Authors:  Stephan Watkins; Werner J Pichler
Journal:  PLoS One       Date:  2013-10-07       Impact factor: 3.240

5.  Effect of Gloriosa superba and Catharanthus roseus Extracts on IFN-γ-Induced Keratin 17 Expression in HaCaT Human Keratinocytes.

Authors:  Nattaporn Pattarachotanant; Varaporn Rakkhitawatthana; Tewin Tencomnao
Journal:  Evid Based Complement Alternat Med       Date:  2014-11-10       Impact factor: 2.629

Review 6.  Psoriasis: A STAT3-Centric View.

Authors:  Enzo Calautti; Lidia Avalle; Valeria Poli
Journal:  Int J Mol Sci       Date:  2018-01-06       Impact factor: 5.923

7.  Signs of innate immune activation and premature immunosenescence in psoriasis patients.

Authors:  Liisi Šahmatova; Elena Sügis; Marina Šunina; Helen Hermann; Ele Prans; Maire Pihlap; Kristi Abram; Ana Rebane; Hedi Peterson; Pärt Peterson; Külli Kingo; Kai Kisand
Journal:  Sci Rep       Date:  2017-08-08       Impact factor: 4.379

8.  Hypomethylation of HLA-DRB1 and its clinical significance in psoriasis.

Authors:  Wenkai Zong; Yiping Ge; Yue Han; Xueyuan Yang; Qi Li; Min Chen
Journal:  Oncotarget       Date:  2017-02-14

Review 9.  The contribution of IL-17 to the development of autoimmunity in psoriasis.

Authors:  Masutaka Furue; Takafumi Kadono
Journal:  Innate Immun       Date:  2019-05-24       Impact factor: 2.680

Review 10.  Keratin 6, 16 and 17-Critical Barrier Alarmin Molecules in Skin Wounds and Psoriasis.

Authors:  Xiaowei Zhang; Meimei Yin; Ling-Juan Zhang
Journal:  Cells       Date:  2019-08-01       Impact factor: 6.600

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.